Immunocore Holdings plc (IMCR) total debt
Immunocore Holdings plc (IMCR) carried total debt of $436.69M at the end of fiscal 2025 (December 31, 2025). That is 0.9% higher than the $432.72M of fiscal 2024. Figures as of 18 Nov 2026, 08:22 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total debt, fiscal 2025
- $436.69M
- Change on fiscal 2024
- +0.9%
- Highest on record
- $436.69Mfiscal 2025
- Lowest on record
- $81.45Mfiscal 2022
- Fiscal years on record
- 42022–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Immunocore Holdings plc total debt, in more detail
Across the 4 fiscal years on record (2022–2025), the highest was $436.69M in fiscal 2025 and the lowest $81.45M in fiscal 2022.
Total debt was 1.1× shareholders' equity at the end of fiscal 2025.
Total debt by fiscal year
Immunocore Holdings plc total debt, year by year
| Fiscal year | Total debt | Change | Year ended | Debt ÷ equity |
|---|---|---|---|---|
| 2025 | $436.69M | 0.9% up | 1.1× | |
| 2024 | $432.72M | 409.0% up | 1.2× | |
| 2023 | $85.01M | 4.4% up | 0.2× | |
| 2022 | $81.45M | — | 0.2× |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.
How to read it
Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.
Immunocore Holdings plc, figure by figure
- Immunocore Holdings plc market cap
- Immunocore Holdings plc revenue
- Immunocore Holdings plc earnings
- Immunocore Holdings plc earnings per share (EPS)
- Immunocore Holdings plc P/E ratio
- Immunocore Holdings plc P/S ratio
- Immunocore Holdings plc P/B ratio
- Immunocore Holdings plc free cash flow
- Immunocore Holdings plc operating margin
- Immunocore Holdings plc dividend
- Immunocore Holdings plc shares outstanding
- Immunocore Holdings plc cash on hand
- Immunocore Holdings plc total assets
- Immunocore Holdings plc return on equity (ROE)
- Immunocore Holdings plc return on invested capital (ROIC)
Immunocore Holdings plc (IMCR) overview: price, valuation and scorecard
Immunocore Holdings plc total debt: questions and answers
How much debt does Immunocore Holdings plc have?
Immunocore Holdings plc (IMCR) carried total debt of $436.69M at the end of fiscal 2025 (December 31, 2025). That is 0.9% higher than the $432.72M of fiscal 2024.
What are the highest and lowest total debt figures on record for Immunocore Holdings plc?
Across the 4 fiscal years on record (2022–2025), the highest was $436.69M in fiscal 2025 and the lowest $81.45M in fiscal 2022.
How does Immunocore Holdings plc's debt compare with its equity?
Total debt was 1.1× shareholders' equity at the end of fiscal 2025.
How is Immunocore Holdings plc's total debt calculated?
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.
Fiscal years are named for the calendar year they end in.
Learn: total debt
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Immunocore Holdings plc (IMCR) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/IMCR/total-debt
Underlying data: the company's filings with the SEC and Yahoo Finance.